These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8427678)

  • 41. Cytochrome P-450 inhibition blocks bone resorption in vitro and in vivo.
    Choo MJ; Chole RA
    Otolaryngol Head Neck Surg; 1999 Jan; 120(1):84-91. PubMed ID: 9914554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytokines and local factors which affect osteoclast function.
    Mundy GR
    Int J Cell Cloning; 1992 Jul; 10(4):215-22. PubMed ID: 1645029
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro.
    Lakkakorpi PT; Väänänen HK
    J Bone Miner Res; 1991 Aug; 6(8):817-26. PubMed ID: 1664645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formation.
    Thudium CS; Moscatelli I; Flores C; Thomsen JS; Brüel A; Gudmann NS; Hauge EM; Karsdal MA; Richter J; Henriksen K
    Calcif Tissue Int; 2014 Jul; 95(1):83-93. PubMed ID: 24838599
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SNX10 is required for osteoclast formation and resorption activity.
    Zhu CH; Morse LR; Battaglino RA
    J Cell Biochem; 2012 May; 113(5):1608-15. PubMed ID: 22174188
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor.
    Mentaverri R; Kamel S; Wattel A; Prouillet C; Sevenet N; Petit JP; Tordjmann T; Brazier M
    J Cell Biochem; 2003 Apr; 88(6):1145-56. PubMed ID: 12647297
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between interleukin-1 and prostaglandins in resorbing neonatal calvaria.
    Garrett IR; Mundy GR
    J Bone Miner Res; 1989 Oct; 4(5):789-94. PubMed ID: 2816521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro.
    Lader CS; Flanagan AM
    Endocrinology; 1998 Jul; 139(7):3157-64. PubMed ID: 9645689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression of osteoclast stimulating and differentiating factors in a murine model of localized inflammatory bone resorption].
    Sudhoff H; Liebehenz Y; Aschenbrenner J; Euteneuer S; Ebmeyer J; Bernal-Sprekelsen M; Stark T; Dazert S
    Laryngorhinootologie; 2004 Jan; 83(1):14-9. PubMed ID: 14740300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent advances in osteoclast biology and pathological bone resorption.
    Blair HC; Athanasou NA
    Histol Histopathol; 2004 Jan; 19(1):189-99. PubMed ID: 14702187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Amplitude and phase of cochlear microphonics as a function of the changes of pressure inside the tympanic bulla in the gerbil and guinea pig].
    AUBRY M; PIALOUX P; BURGEAT M
    Ann Otolaryngol; 1962 Jun; 79():387-94. PubMed ID: 13863191
    [No Abstract]   [Full Text] [Related]  

  • 52. Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis.
    Kameda T; Miyazawa K; Mori Y; Yuasa T; Shiokawa M; Nakamaru Y; Mano H; Hakeda Y; Kameda A; Kumegawa M
    Biochem Biophys Res Commun; 1996 Mar; 220(3):515-9. PubMed ID: 8607797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathogenic factors in bone resorption in cholesteatoma.
    Abramson M; Moriyama H; Huang CC
    Acta Otolaryngol; 1984; 97(5-6):437-42. PubMed ID: 6205536
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extracellular acidosis accelerates bone resorption by enhancing osteoclast survival, adhesion, and migration.
    Ahn H; Kim JM; Lee K; Kim H; Jeong D
    Biochem Biophys Res Commun; 2012 Feb; 418(1):144-8. PubMed ID: 22244876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence that activation of ASIC1a by acidosis increases osteoclast migration and adhesion by modulating integrin/Pyk2/Src signaling pathway.
    Li X; Ye JX; Xu MH; Zhao MD; Yuan FL
    Osteoporos Int; 2017 Jul; 28(7):2221-2231. PubMed ID: 28462470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stimulation of bone resorption and osteoclast clear zone formation by low pH: a time-course study.
    Murrills RJ; Stein LS; Dempster DW
    J Cell Physiol; 1993 Mar; 154(3):511-8. PubMed ID: 8436600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cellular and subcellular events of bone resorption in human and experimental cholesteatoma: the role of osteoclasts.
    Chole RA
    Laryngoscope; 1984 Jan; 94(1):76-95. PubMed ID: 6361431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Osteoclasts in chronic otitis media, cholesteatoma, and otosclerosis.
    Chole RA
    Ann Otol Rhinol Laryngol; 1988; 97(6 Pt 1):661-6. PubMed ID: 3202569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Osteoclasts and integrins.
    Teitelbaum SL
    Ann N Y Acad Sci; 2006 Apr; 1068():95-9. PubMed ID: 16831909
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Macrophage inflammatory protein-1 alpha and IL-8 stimulate the motility but suppress the resorption of isolated rat osteoclasts.
    Fuller K; Owens JM; Chambers TJ
    J Immunol; 1995 Jun; 154(11):6065-72. PubMed ID: 7751648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.